Pharmapedia

GENERIC VERSUS BRANDED MEDICINES AVAILABLE ON THE LOCAL MARKET

ABOUT AUTHORS
Hanan. M. El Bsir1,  Mokhtar. M. El-Baseir2, Abdulrhman  .A . Akasha2*,  Somaia.A . Elsaedi3  and Abdrheam Eluzy2.
1National Medical Research Center,
Zawia, Libya
2Department of Pharmaceutics,
Faculty of Pharmacy, University of Tripoli, Libya
3Minstry of Health,
Tripoli, Libya

ABSTRACT 
This paper presents a survey study of generic and branded medicines available on the local market. The study was carried out on solid dosage forms (Tablets and capsules) for 53 medications available at the time of study in 69 pharmacies located in Tripoli, Libya. Physical specifications (generic name, batch number, manufacture date, expiry date and the manufacturer) as appeared on the package for each product were recorded in a designed form. The retail price at the time of study for each innovator brand and the counterpart generic was also recorded and compared. Results showed that 234 (89%) generics and 29 (11%) branded medicines were available for the studied medicines. The generics medicines were antibiotics (28%), cardiovascular (24.36%), analgesics and antipyretics (12.5%), gastrointestinal (12.8%), for respiratory tract (0.85%), anti-Anthistamin (7.26%), for adiabatic (3%), for vitamins and minerals (6%) and corticosteroid (1%) medicines. The original suppliers of the generics were European countries (42%), Arabian countries (41%) and other region of the world (17%). The retail prices for the generics were significantly (p > 0.05) lower compared to the price of innovator brand counterpart. The study suggests post-marketing surveillance studies for the available generics in comparison to the innovators especially in terms of therapeutic efficiency.

3 FACTS THAT PUSHED AN INDUSTRY FROM ASPIRIN TO ASPIRATION

How technology and innovation will drive the Pharma industry.

Ever since the pyramids were erected in Giza, the need for medication and surgery were required.

During the Stone Age, as early as 3,300 B.C, studies have shown that primitive forms of herbal condiments were used to treat wounds and certain lung disorders. Ayurveda, from the annals of the Hindu Veda scriptures, can be traced back to almost 4,000 B.C. The first institution to train individuals in the field of physiology and medication was established in Italy, around the 15th century.

Why do some microbes live in your gut while others don't?

Trillions of tiny microbes and bacteria live in your gut, each with their own set of genes. These gut microbes can have both beneficial and harmful effects on your health, from protecting you against inflammation to causing life-threatening infections. To keep out pathogens yet encourage the growth of beneficial microbes, scientists have been trying to find ways to target specific microbial genes.

The Needle-free Injection Technology Enjoys Tremendous Opportunity

Injections are a common method of injecting drugs into a patient to prevent or cure diseases. However, it is an invasive mode of drug administration as it causes tissue damage. Moreover, injections can cause the transmission of diseases, especially when needles are repeated or used incorrectly. To get rid of these obstacles, the needle-free injection technology (NFIT) was developed. It has gained enormous popularity in the past few years due to its potential of making the administration of drugs more efficient, safe, less expensive, and convenient.

IN NEXT 25 YEARS PHARMACEUTICAL SCIENCES/MEDICAL SCIENCES PHRASE WILL BE OBSOLETE, AS SMART BODY WILL COME IN AND ARTIFICIAL INTELLIGENCE WILL PLAY CRUCIAL ROLE

ABOUT AUTHOR
Dr. Amit Gangwal
gangwal.amit@gmail.com

A new set of global guidelines on managing diabetes (that plan to replace those followed nearly for thirty years) has been released by American College of Physicians, organization comprising internal medicine physicians. The same has been published in medical journal Annals of Internal Medicine. It says clinicians should aim to achieve an HbA1c level between 7% and 8% in most patients with type 2 diabetes (against the current 6.5 to 7%). This new figure has caused disagreement within the medical community. Medical practitioners in India opine that this may lead to serious complications in diabetics; so it should be ignored for Indians. There were around 72 million diabetics in India in 2017 (as per International Diabetes Federation). HbA1c is long-term blood sugar target, hemoglobin A1C (HbA1c) and it is an estimation of a person’s average blood sugar level over the past few months1.

Speeded-Up Drug Approval Process Will Boost Biologics Market

  • Posted on: 4 July 2018
  • By: PharmaTutor News

The US Federal Drug Administration is aiming to cut the time-to-market and the development costs for new drugs. This will help drive growth in the market for biologics, where over 1000 drugs are currently under development, to 9.6% year on year from its recent rate of 5.4%. Unlike small-molecule drugs that are manufactured through organic or inorganic chemical synthesis, biologics are manufactured by living cells. Biologics are more complex, fragile and difficult to manufacture than small molecules. They cost more to bring to market than the $2 billion average to develop a new drug, despite a trend to outsource development to contract research organizations.

ADVANCED TECHNOLOGY ON ACCURACY IN DETECTION OF BREAST CANCER

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
SUJATHA RAMASAMY 1*, SRIKANTA PRIYADARSHAN PATRA 1,PULAK RANJAN BASAK 1,
1Technology Information, Forecasting and Assessment Council (TIFAC)-DST, New Delhi, India.
*sujathar23@gmail.com

ABSTRACT:
Breast cancer is one of the leading type of cancer in India. Current methods used in detection of cancer like mammography combined with Digital Infrared Imaging can help learn about  earlier stages of cancer with accuracy.The Niramai an Indian startup developed a software with machine learning and artificial intelligence which can detect and sense cancer cells that are 5 times smaller than what has been done presently. The method is non-contact, painless and free of radiation. This method can help detection of cancer in very early stage before showing any suspicious or alarming signs.

Growth In The Pharmaceuticals Market

The global pharma market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, a report from The Business Research Company shows. This is an accelerated pace compared to 5.2% for the years before 2017, but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

Pages